Eric Weiner$1.2MFollowers@eweiner07/19/2023Bought 100% more AXSMAxsome Therapeutics at $73.68 0123456789
Mike Pelech$11.2MFollowers@mpelech11/08/2022Sold all AXSM2.12% GAINAxsome Therapeutics at $61.91 0123456789
Mike Pelech$11.2MFollowers@mpelech11/08/2022Sold 40% of AXSM8.16% GAINAxsome Therapeutics at $65.58 0123456789
Mike Pelech$11.2MFollowers@mpelech11/08/2022Sold 33% of AXSM3.08% GAINAxsome Therapeutics at $62.50 0123456789
Mike Pelech$11.2MFollowers@mpelech11/08/2022New position in AXSMAxsome Therapeutics at $60.63 0123456789
Eric Weiner$1.2MFollowers@eweiner10/31/2022New position in AXSMAxsome Therapeutics at $45.39 0123456789
Abilash Satya$11.4MFollowers@abilash06/30/2022Sold all AXSM3.21% GAINAxsome Therapeutics at $38.28 0123456789
Abilash Satya$11.4MFollowers@abilash06/30/2022Sold 50% of AXSM3.21% GAINAxsome Therapeutics at $38.28 0123456789
Abilash Satya$11.4MFollowers@abilash06/28/2022Bought 100% more AXSMAxsome Therapeutics at $37.09 0123456789
Abilash Satya$11.4MFollowers@abilash06/28/2022New position in AXSMAxsome Therapeutics at $37.09 0123456789
Abilash Satya$11.4MFollowers@abilash04/20/2022Sold all AXSM-3.36% LOSSAxsome Therapeutics at $39.68 0123456789
Abilash Satya$11.4MFollowers@abilash04/19/2022New position in AXSMAxsome Therapeutics at $41.06 0123456789
